Inovio Pharma (INO) Promotes SVP Niranjan Sardesai to COO
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Join SI Premium – FREE
Inovio Pharmaceuticals, Inc. (AMEX: INO), has promoted Niranjan Y. Sardesai, Ph.D., from Senior Vice President Research and Development to Chief Operating Officer. In his expanded role, Dr. Sardesai will be responsible for corporate and business development for the company in addition to continuing to oversee research and development. Inovio also announced the retirement of Kevin W. Rassas, former Senior Vice President Business Development.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Ingredion names Diego Reynoso as CFO, effective October 2026
- Simmons Bank chief data officer Lisa Hunter to retire
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
